Last updated on March 2019

Prevention of Episodic Migraine: Long-Term, Randomized, Open-Label Study to Evaluate the Safety and Tolerability of Oral Atogepant


Other Details:

You may be able to use currently prescribed migraine medication as backup treatment. Study related medical care and medical evaluations, physical exams, lab work and all study-related visits are provided at no cost to those who qualify for the study.



Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.